Concentrix Corporation (NASDAQ:CNXC – Get Free Report) CEO Christopher Caldwell acquired 1,000 shares of the stock in a transaction dated Wednesday, July 8th. The shares were acquired at an average cost of $21.25 per share, with a total value of $21,250.00. Following the completion of the transaction, the chief executive officer owned 358,382 shares in the company, valued at approximately $7,615,617.50. This represents a 0.28% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Concentrix Stock Performance
Shares of Concentrix stock opened at $22.20 on Friday. The firm’s 50 day moving average is $25.01 and its two-hundred day moving average is $31.06. Concentrix Corporation has a 52 week low of $19.12 and a 52 week high of $62.14. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46. The firm has a market capitalization of $1.35 billion, a P/E ratio of -1.04, a P/E/G ratio of 0.38 and a beta of 0.47.
Concentrix (NASDAQ:CNXC – Get Free Report) last posted its earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. Concentrix’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the previous year, the company posted $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Research analysts forecast that Concentrix Corporation will post 9.67 EPS for the current fiscal year.
Concentrix Dividend Announcement
Institutional Trading of Concentrix
Several large investors have recently added to or reduced their stakes in CNXC. Thompson Investment Management Inc. grew its stake in shares of Concentrix by 36.9% in the fourth quarter. Thompson Investment Management Inc. now owns 216,154 shares of the company’s stock valued at $8,988,000 after buying an additional 58,251 shares in the last quarter. Invenomic Capital Management LP lifted its position in Concentrix by 19.7% during the 3rd quarter. Invenomic Capital Management LP now owns 822,345 shares of the company’s stock worth $37,951,000 after acquiring an additional 135,429 shares in the last quarter. Hussman Strategic Advisors Inc. boosted its holdings in Concentrix by 100.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock worth $3,493,000 after acquiring an additional 42,000 shares during the period. Pzena Investment Management LLC boosted its holdings in Concentrix by 32.3% in the 4th quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after acquiring an additional 714,604 shares during the period. Finally, Jupiter Asset Management Ltd. acquired a new stake in Concentrix in the fourth quarter valued at approximately $19,385,000. 90.34% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the company. Bank of America cut their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research report on Tuesday, June 30th. Canaccord Genuity Group dropped their price target on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a research note on Tuesday, June 30th. Zacks Research downgraded Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Robert W. Baird reduced their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Finally, Wall Street Zen cut Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $32.75.
Check Out Our Latest Stock Analysis on CNXC
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Articles
- Five stocks we like better than Concentrix
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
